Stroke Clinical Trials

Find Stroke Clinical Trials Near You

The Links Between Executive and Linguistic Processes and Their Lesional Determinants From a Verbal Fluency Task

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Verbal fluency test require to produce as much words as possible in one or two minutes. This test is highly sensitive to main brain diseases and are therefore widely used in clinical routine for diagnostic purpose. The verbal fluency task requires several cognitive processes including executive and linguistic processes for which it is difficult to extract the origin of the deficit. For this reason, fluency tests are variably interpreted in terms of executive or language. The implementation of an experimental protocol exploring each of these processes separately and studying the links between the verbal fluency task and each of these processes should allow a better understanding of the origin of the verbal fluency deficit after brain injury and improve the identification of key brain structures. Indeed, the lesion determinants of this task remain to be clarified despite remarkable advances due to the evolution of imaging techniques (voxel-based lesion-symptom mapping (VLSM); voxel-based morphometry (VBM)). Furthermore, while the direct assessment of linguistic process, semantic memory, and processing speed is well defined, the examination of the executive component (i.e., strategic search process) remains unsettled and will be undertaken in this study. This work will take advantage of data from previous multicenter work, validated methodologies for both analysis and interpretation of cognitive performance as well as anatomic-clinical correlations at the voxel level and will be performed in cognitive neurodegenerative and cerebrovascular disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• For Cognitive cortical neurodegenerative diseases PATIENTS

• informed consentPatients between 40 and 85 years old,

• French native language,

• Social Security affiliation,

• Can read, write and count (up to 36) and knows the alphabet

• Assessed in Amiens University Memory Clinic for:

• Mild severity impairment (MMSE\> 19) or major severity impairment related to:

• AD according to Albert criteria and McKhann criteria

• DCL according to McKeith criteria

• FTLD according to Rascovsky criteria

• CBD according to Armstrong's criteria

• PSP according to Höglinger criteria

• For Stroke PATIENTS

• informed consent

• Patients between 40 and 85 years old,

• French native language,

• Social Security affiliation,

• Can read, write and count (up to 36) and knows the alphabet

• Having suffered a stroke, hospitalized in neurology, visualized by imaging

Locations
Other Locations
France
CHU Amiens
RECRUITING
Amiens
Contact Information
Primary
Martine ROUSSEL, PhD
roussel.martine@chu-amiens.fr
0322668240
Time Frame
Start Date: 2023-05-16
Estimated Completion Date: 2029-11
Participants
Target number of participants: 302
Treatments
Experimental: Cognitive cortical neurodegenerative diseases and stroke PATIENTS
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire, Amiens

This content was sourced from clinicaltrials.gov